
BIOLASE BIOL
Quarterly report 2024-Q3
added 11-07-2024
BIOLASE Interest Expense 2011-2026 | BIOL
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense BIOLASE
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | -1 K | 42 K | 70 K | 74 K | - | -27 K | 239 K | 305 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 305 K | -27 K | 100 K |
Quarterly Interest Expense BIOLASE
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1 K | - | - | 1 K | 1 K | - | 29 K | 19 K | 9 K | - | 52 K | 33 K | 16 K | - | 44 K | 23 K | - | - | - | -15 K | - | - | - | - | - | - | 98 K | 38 K | 5 K | - | 2 K | 6 K | 73 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 98 K | -15 K | 24.2 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
45.9 M | $ 11.94 | -1.73 % | $ 1.79 B | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.3 | 2.51 % | $ 910 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 36.29 | 4.1 % | $ 5.41 K | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 9.34 | -1.79 % | $ 264 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 8.95 | -1.65 % | $ 321 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.35 | 0.05 % | $ 120 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.26 | -2.92 % | $ 167 M | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 84.81 | -0.61 % | $ 2.95 B | ||
|
LivaNova PLC
LIVN
|
664 K | $ 63.31 | 0.11 % | $ 3.45 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
LENSAR
LNSR
|
660 K | $ 5.87 | -3.29 % | $ 67.6 M | ||
|
Medtronic PLC
MDT
|
402 M | $ 86.97 | -0.23 % | $ 112 B | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 11.88 | 0.08 % | $ 470 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
167 K | $ 32.34 | 1.86 % | $ 1.49 B | ||
|
Penumbra
PEN
|
893 K | $ 335.16 | -0.12 % | $ 13 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.38 | -0.68 % | $ 1.13 B | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 224.56 | -1.11 % | $ 15.8 B | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 5.22 | -3.33 % | $ 180 M | ||
|
Electromed
ELMD
|
78 K | $ 24.4 | -0.37 % | $ 206 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Quanterix Corporation
QTRX
|
157 K | $ 3.75 | -4.82 % | $ 160 M | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.24 | -2.61 % | $ 3.5 M | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.58 | 1.18 % | $ 7.16 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 10.96 | 5.68 % | $ 1.48 B | ||
|
Myomo
MYO
|
-668 K | $ 0.72 | 2.1 % | $ 30.1 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 100.0 | 0.81 % | $ 1.27 B |